Polymun Scientific 2012 marks the twentieth anniversary of Polymun. Can you describe to our readers the origins of the company and how it compares to your expectations in 1992? Prior to founding Polymun, I worked as a professor for the Institute of Applied Microbiology at the University of Natural Resources and Applied…
BioSingapore In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore and describe its main objectives? BioSingapore was created in 2004 by the Singapore Economic Development Board (EDB) to create an interactive platform for the…
Grupo Vitalmex Mexico Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at the center. We focus on a very specific strategy based on 3 goals: Accessibility, availability, and opportunity. There is clearly…
Pfizer Ireland You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines that met robust medical need; second, there was a promising pipeline of medical advances; third, there were less budgetary constraints, and more localized decision…
Department of Health and Children Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this Department when you took over the position of Secretary General? For me, it is a privilege to support a Minister that is very determined…
PwC Mexico PwC has been the advocate of convergence in the industry for a very long time, what does that mean and what are the implications for the Mexican healthcare system? At PwC we have a common view for the health sector globally. We think that accessing cost-effective quality care is a…
Meda Pharma Austria What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there was a distinct lack of enthusiasm and forward thinking strategy. Because the financial investors running Viatris wanted to sell the…
DHL Supply Chain Mexico One of the most drastic changes the healthcare industry has faced recently is the phenomenal growth of generics in the Mexican market. Which solutions does DHL offer to the market to address the distribution of generics in the country? DHL Supply Chain keeps a keen eye on the changes our…
Savira pharmaceuticals You previously worked as CSO for onepharm; what was the motivation for creating Savira? OS: When I was working at onepharm, the organization was focused on anti-influenza and anti-inflammatory drug development. In late 2008, the enterprise management organization of the European Molecular Biology Laboratory (EMBL) was seeking for an industrial…
Irish Pharmaceutical Healthcare Association With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they have adjusted to the recent climate in Ireland. Miss Nolan, you have been chief executive of the IPHA since 1994. How have you seen…
TranScrip Partners Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin by introducing TranScrip Partners to our readers? Dr. Sree Haran: TranScrip Partners was founded in 2008, and differs from the…
TranScrip Partners Senior Partner Dr Sree Haran has also participated in this interview. TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin by introducing TranScrip Partners to our readers? Dr. Sree Haran: TranScrip Partners was founded in 2008, and differs…
See our Cookie Privacy Policy Here
